Pentadecanal

Details

Top
Internal ID 5b6d9703-4982-4244-8632-91ece4e717e4
Taxonomy Lipids and lipid-like molecules > Fatty Acyls > Fatty aldehydes
IUPAC Name pentadecanal
SMILES (Canonical) CCCCCCCCCCCCCCC=O
SMILES (Isomeric) CCCCCCCCCCCCCCC=O
InChI InChI=1S/C15H30O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16/h15H,2-14H2,1H3
InChI Key XGQJZNCFDLXSIJ-UHFFFAOYSA-N
Popularity 206 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H30O
Molecular Weight 226.40 g/mol
Exact Mass 226.229665576 g/mol
Topological Polar Surface Area (TPSA) 17.10 Ų
XlogP 6.50
Atomic LogP (AlogP) 5.28
H-Bond Acceptor 1
H-Bond Donor 0
Rotatable Bonds 13

Synonyms

Top
2765-11-9
1-pentadecanal
n-pentadecanal
Pentadecanal-
PXR39QX5Q7
pentadecaldehyde
Pentadecanaldehyde
Pentadecyl Aldehyde
pentadecan-15-one
UNII-PXR39QX5Q7
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Pentadecanal

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9948 99.48%
Caco-2 + 0.8841 88.41%
Blood Brain Barrier + 1.0000 100.00%
Human oral bioavailability - 0.5143 51.43%
Subcellular localzation Mitochondria 0.3433 34.33%
OATP2B1 inhibitior - 0.8509 85.09%
OATP1B1 inhibitior + 0.9024 90.24%
OATP1B3 inhibitior + 0.9214 92.14%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9500 95.00%
BSEP inhibitior - 0.6270 62.70%
P-glycoprotein inhibitior - 0.9459 94.59%
P-glycoprotein substrate - 0.9337 93.37%
CYP3A4 substrate - 0.7002 70.02%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7756 77.56%
CYP3A4 inhibition - 0.9876 98.76%
CYP2C9 inhibition - 0.9372 93.72%
CYP2C19 inhibition - 0.9645 96.45%
CYP2D6 inhibition - 0.9645 96.45%
CYP1A2 inhibition + 0.7096 70.96%
CYP2C8 inhibition - 0.9715 97.15%
CYP inhibitory promiscuity - 0.9015 90.15%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.5900 59.00%
Carcinogenicity (trinary) Non-required 0.7426 74.26%
Eye corrosion + 0.9967 99.67%
Eye irritation + 0.9824 98.24%
Skin irritation + 0.8808 88.08%
Skin corrosion - 0.8416 84.16%
Ames mutagenesis - 0.9900 99.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4070 40.70%
Micronuclear - 1.0000 100.00%
Hepatotoxicity - 0.6691 66.91%
skin sensitisation + 0.8238 82.38%
Respiratory toxicity - 1.0000 100.00%
Reproductive toxicity - 0.9584 95.84%
Mitochondrial toxicity - 1.0000 100.00%
Nephrotoxicity + 0.6700 67.00%
Acute Oral Toxicity (c) III 0.8649 86.49%
Estrogen receptor binding - 0.7956 79.56%
Androgen receptor binding - 0.8204 82.04%
Thyroid receptor binding + 0.6248 62.48%
Glucocorticoid receptor binding - 0.7875 78.75%
Aromatase binding - 0.7521 75.21%
PPAR gamma + 0.6239 62.39%
Honey bee toxicity - 0.9862 98.62%
Biodegradation + 0.9500 95.00%
Crustacea aquatic toxicity + 0.8784 87.84%
Fish aquatic toxicity + 0.8971 89.71%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL230 P35354 Cyclooxygenase-2 96.51% 89.63%
CHEMBL4769 O95749 Geranylgeranyl pyrophosphate synthetase 95.17% 92.08%
CHEMBL2581 P07339 Cathepsin D 93.42% 98.95%
CHEMBL3892 Q99500 Sphingosine 1-phosphate receptor Edg-3 91.30% 97.29%
CHEMBL2265 P23141 Acyl coenzyme A:cholesterol acyltransferase 91.25% 85.94%
CHEMBL2955 O95136 Sphingosine 1-phosphate receptor Edg-5 89.79% 92.86%
CHEMBL3060 Q9Y345 Glycine transporter 2 89.28% 99.17%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 86.57% 96.09%
CHEMBL1293267 Q9HC97 G-protein coupled receptor 35 85.14% 89.34%
CHEMBL5043 Q6P179 Endoplasmic reticulum aminopeptidase 2 83.61% 91.81%
CHEMBL2664 P23526 Adenosylhomocysteinase 82.42% 86.67%
CHEMBL3401 O75469 Pregnane X receptor 81.91% 94.73%
CHEMBL221 P23219 Cyclooxygenase-1 81.76% 90.17%

Cross-Links

Top
PubChem 17697
NPASS NPC265705
LOTUS LTS0154664
wikiData Q27102309